NO924751L - Prp-overproduserende haemophilus influenzae-stamme - Google Patents
Prp-overproduserende haemophilus influenzae-stammeInfo
- Publication number
- NO924751L NO924751L NO92924751A NO924751A NO924751L NO 924751 L NO924751 L NO 924751L NO 92924751 A NO92924751 A NO 92924751A NO 924751 A NO924751 A NO 924751A NO 924751 L NO924751 L NO 924751L
- Authority
- NO
- Norway
- Prior art keywords
- haemophilus influenzae
- overproducing
- prp
- stem
- ribitol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/21—Haemophilus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80386691A | 1991-12-09 | 1991-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO924751D0 NO924751D0 (no) | 1992-12-08 |
NO924751L true NO924751L (no) | 1993-06-10 |
Family
ID=25187649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92924751A NO924751L (no) | 1991-12-09 | 1992-12-08 | Prp-overproduserende haemophilus influenzae-stamme |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0546349A3 (de) |
JP (1) | JPH05292949A (de) |
KR (1) | KR930013097A (de) |
AU (1) | AU670924B2 (de) |
CA (1) | CA2084746A1 (de) |
FI (1) | FI925571A (de) |
IL (1) | IL104017A0 (de) |
NO (1) | NO924751L (de) |
TW (1) | TW219374B (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007690B1 (de) * | 1978-06-06 | 1982-10-06 | TATE & LYLE PATENT HOLDINGS LIMITED | Verfahren zur Herstellung eines Polysaccharids |
CA1209036A (en) * | 1982-08-20 | 1986-08-05 | Joseph S.C. Kuo | Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine |
US4894331A (en) * | 1985-09-27 | 1990-01-16 | Amgen Inc. | Partial marker cassette mutagenesis of xylose isomerase |
-
1992
- 1992-11-16 EP EP19920119535 patent/EP0546349A3/en not_active Withdrawn
- 1992-12-07 CA CA002084746A patent/CA2084746A1/en not_active Abandoned
- 1992-12-07 IL IL104017A patent/IL104017A0/xx unknown
- 1992-12-08 TW TW081109827A patent/TW219374B/zh active
- 1992-12-08 KR KR1019920023615A patent/KR930013097A/ko not_active Application Discontinuation
- 1992-12-08 FI FI925571A patent/FI925571A/fi unknown
- 1992-12-08 NO NO92924751A patent/NO924751L/no unknown
- 1992-12-08 JP JP4351358A patent/JPH05292949A/ja active Pending
- 1992-12-09 AU AU30017/92A patent/AU670924B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU3001792A (en) | 1993-06-10 |
FI925571A (fi) | 1993-06-10 |
FI925571A0 (fi) | 1992-12-08 |
AU670924B2 (en) | 1996-08-08 |
JPH05292949A (ja) | 1993-11-09 |
IL104017A0 (en) | 1993-05-13 |
EP0546349A3 (en) | 1994-06-08 |
TW219374B (de) | 1994-01-21 |
KR930013097A (ko) | 1993-07-21 |
NO924751D0 (no) | 1992-12-08 |
CA2084746A1 (en) | 1993-06-10 |
EP0546349A2 (de) | 1993-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO905617D0 (no) | Etterfyllbar beholder, samt preform for forming av samme. | |
NO892099D0 (no) | Anvendelse av 1,1,1,4,4,4-heksafluorbutan som driv- og demmegass for fremstilling av plastskumstoffer. | |
NO980059L (no) | Nye oksazolidinonderivater, fremgangsmåte for fremstilling av dem, samt medikamenter som inneholder disse forbindelsene | |
FI895225A0 (fi) | Foerfarande foer borttagning av tungmetaller, saerskilt kadmium, fraon loesningar som innehaoller fosforsyra. | |
FI880752A0 (fi) | Anvaendning v neisseria gonorrhoeae -lektin som vaccin och som diagnostiskt markeringsaemne, samt produktionsfoerfarande av denna lektin. | |
FI900870A0 (fi) | Foerfarande foer belaeggning av papper med kompositioner, som innehaoller mikrokapslar. | |
FI883646A0 (fi) | 1-fenyl-3-(1-piperazinyl)-1h -indazoler, foerfarande och mellanprodukter foer deras framstaellning samt anvaendning av dessa som laekemedel. | |
NO924751L (no) | Prp-overproduserende haemophilus influenzae-stamme | |
HUP9602640A2 (en) | Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds. | |
NL190876B (nl) | Eruptieafsluiter met ringvormige pakker, alsmede pakker hiervoor. | |
HUP9602262A3 (en) | Prostaglandin derivatives, pharmaceutical compns. contg. them and process for preparing the said compds. | |
ES481357A1 (es) | Procedimiento para la produccion de los antibioticos s 54832a-i, s 54832-a-ii, s 54832-a-iii, s 54832-a-iv | |
AU3018289A (en) | Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions, and vaccine | |
DK423084A (da) | 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b, dens 4ae-epimer og farmaceutisk acceptable salte deraf samt forbindelser til anvendelsen som mellemprodukter ved fremstilling deraf | |
DK0456033T3 (da) | Fremgangsmåde til fremstilling af xylanase | |
IT1230350B (it) | Valvola di prelevamento, specialmente per distribuire bevande. | |
NO950223D0 (no) | Fremgangsmåte for fremstilling av kjeks, samt slik kjeks | |
NO903007D0 (no) | 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter. | |
RO105830B1 (ro) | Procedeu de obtinere, prin biosinteza, a exopolizaharidului de tip pullulan | |
NO884398D0 (no) | Fremgangsmaate for bleking av mekanisk masse. | |
EP0282322A3 (en) | Novel serotonin inhibitors and pharmaceutical compositions containing them, and microbiological processes and organisms for the production thereof | |
JPS521087A (en) | Process for producing amylase | |
PL269985A1 (en) | The method of the limitation of plant viruses infections,which are transfered by the mechanical way. the specific for the limitation of plant viruses infections,transfered by the mechanical way | |
CA995222A (en) | 1,2,4-oxadiazole derivatives | |
CA908157A (en) | PROCESS FOR PREPARING USEFUL 17.alpha.-HYDROXY-20-KETO AND 17.alpha., 21-DIHYDROXY-20-KETO PREGNANES AND DERIVATIVES AND INTERMEDIATES THEREOF |